ESC ICD Primary Prevention Criteria Algorithm

Clinical calculation support · Verify results before clinical use

Clinical eligibility inputs

Enter the patient's clinical status to review common primary-prevention ICD pathways.

ESC-based aid
Select the pathway most applicable to the patient.
Enter a value from 0 to 100.
Use the duration of optimized, tolerated guideline-directed therapy.
Enter 0 if there was no recent MI.

Clinical context and limitations

This tool summarizes selected primary-prevention ICD pathways; it is not a complete guideline algorithm and must not replace specialist assessment or shared decision-making.

Core pathway represented

  • Symptomatic heart failure (NYHA II–III), LVEF ≤35% despite at least 3 months of optimal medical therapy, and expected meaningful survival beyond one year.
  • For ischaemic disease, primary-prevention implantation should not occur within 40 days after MI.
  • For non-ischaemic DCM, an ICD should be considered rather than treating eligibility as automatic; competing mortality, age, comorbidity, patient preference, and contemporary therapy matter.
  • A selected asymptomatic post-MI/CAD pathway may apply to NYHA I with LVEF ≤30% after ≥40 days and ≥3 months of therapy in some guidelines. Confirm the exact applicable guideline before acting.

Not represented in this simplified tool

CRT indications, secondary prevention, genetic or disease-specific risk pathways, myocardial scar on CMR, unexplained syncope, NSVT/electrophysiology findings, reversibility, and local reimbursement or regulatory criteria require separate evaluation.

References

2026 ESC Guidelines for the management of heart failureEuropean Heart Journal. 2026.
2022 ESC Guidelines for ventricular arrhythmias and prevention of sudden cardiac deathEuropean Heart Journal. 2022.
2021 ESC Guidelines for diagnosis and treatment of acute and chronic heart failureEuropean Journal of Heart Failure. 2021.
2022 AHA/ACC/HFSA Guideline for the Management of Heart FailureJournal of the American College of Cardiology. 2022.
Clinical disclaimer: Educational decision support only. The result does not establish or exclude ICD eligibility. Confirm the current guideline, underlying diagnosis, timing after MI/revascularization, duration and optimization of therapy, comorbidities, competing risks, patient preferences, and specialist/device-team assessment before any clinical decision.